Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.30
20.03.23
-
20.03.24
6.18%
23.03.23

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
buy
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€26.85
14.03.22
€40.00
14.03.23
36.78%
11.03.23

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.37
21.07.22
€5.30
21.07.23
-21.42%
11.03.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Fission Uranium Corp.

Start price
Target price
Perf. (%)
€0.62
26.02.22
-
26.02.23
-10.97%
27.02.23

buy
Eco Atlantic Oil and Gas Ltd

Start price
Target price
Perf. (%)
€0.37
24.02.22
-
24.02.23
-36.56%
25.02.23

Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€3.32
14.11.22
-
14.11.23
-8.52%
24.02.23

Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
Denison Mines Corp.

Start price
Target price
Perf. (%)
€1.31
25.01.23
-
25.01.24
-14.12%
24.02.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€10.10
21.02.22
-
21.02.23
-35.47%
22.02.23

Could be very worthwhile Investment >20% year
buy
GoviEx Uranium Inc

Start price
Target price
Perf. (%)
€0.21
17.02.22
-
17.02.23
-30.24%
18.02.23

buy
Dynacor Group Inc.

Start price
Target price
Perf. (%)
€2.16
15.02.22
-
15.02.23
-4.63%
16.02.23

buy
Lithium Americas Corp.

Start price
Target price
Perf. (%)
€25.70
10.02.22
€33.00
10.02.23
-8.75%
11.02.23

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Future proof or reliable business model
Low dividend yield expected
buy
New Gold Inc.

Start price
Target price
Perf. (%)
€1.51
08.02.22
€1.85
08.02.23
-35.14%
09.02.23

Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
buy
Ur-Energy Inc.

Start price
Target price
Perf. (%)
€1.05
07.02.22
-
07.02.23
8.29%
08.02.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Growths faster than the competition
Future proof or reliable business model
buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€3.70
05.02.22
€10.00
05.02.23
-72.82%
06.02.23

Could be worthwhile Investment >10% per year
positive Cash Flow expected
Standard Investments for future growth
EBIT decline/stagnation expected
buy
Nexgen Energy Ltd

Start price
Target price
Perf. (%)
€3.69
05.02.22
€6.00
05.02.23
12.57%
06.02.23

Could be worthwhile Investment >10% per year
Fair valuation
positive Cash Flow expected
Mag Silver Corp.

Start price
Target price
Perf. (%)
€12.89
17.10.22
-
17.10.23
-2.21%
30.01.23

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Lithium Americas Corp.

Start price
Target price
Perf. (%)
€22.14
29.01.22
€28.00
29.01.23
-5.17%
30.01.23

Could be worthwhile Investment >10% per year
buy
Nano One Materials Corp

Start price
Target price
Perf. (%)
€2.20
28.01.22
-
28.01.23
-8.43%
29.01.23

Could be worthwhile Investment >10% per year
Jaguar Mining Inc.

Start price
Target price
Perf. (%)
€2.05
17.10.22
-
17.10.23
-4.87%
23.01.23

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€1.50
21.07.22
€1.00
21.07.23
-44.89%
11.01.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Energy Fuels Inc.

Start price
Target price
Perf. (%)
€5.78
13.12.22
-
13.12.23
8.44%
11.01.23

Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€0.98
14.12.21
-
14.12.22
-39.08%
15.12.22

Could be worthwhile Investment >10% per year
buy
Aris Mining Corp.

Start price
Target price
Perf. (%)
€3.91
02.04.22
-
02.04.23
-20.12%
03.12.22

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€4.85
01.12.21
-
01.12.22
-53.67%
02.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.05
20.09.22
€1.80
20.09.23
36.59%
19.11.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected